CHRISTY BURD: Open Payments
NPI 1003552639 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 8 payments from 6 companies in 2025. Trend: 2023 $403 · 2024 $261 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 1 | $22 |
| Phadia US Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, KISUNLA, ImmunoCAP, Ozempic, XIFAXAN, Cologuard Collection Kit.
Industry payments across WY — which companies pay providers there.
